More speakers announced for the 2024 STAT Summit — Agenda release coming soon

STAT SUMMIT NEWS

The 2024 STAT Summit agenda is scheduled for release in early September and the lineup is growing fast. Below are some of the new faces taking the stage this October — Follow along here for updates.

Featured this week: Jane Grogan, Ph.D.

We're thrilled to welcome Dr. Jane Grogan, EVP and Head of Research at Biogen, to the STAT Summit.

With nearly two decades of biotech leadership, including pivotal roles at Genentech and groundbreaking research in immunology and oncology, Dr. Grogan is uniquely positioned to address the complexities of change and innovation in medicine. She will share insights into her latest work at Biogen and her perspective on the future of pharma R&D.

Only 95 General Admission tickets left—secure your spot today!

REGISTER NOW

Featured Speakers:

Jane Grogan, Ph.D.

Executive Vice President and Head of Research, Biogen

Daphne Zohar

Founder, CEO, and Board Member of Seaport Therapeutics

Dave Marver

CEO, Onward Medical

Jazmin Evans

Kidney Transplant Survivor; Advocate for Equity in Healthcare and Solid Organ Transplant Systems

Yvonne Greenstreet

CEO, Alnylam Pharmaceuticals

D.A. Wallach

Venture Capital Investor and Recording Artist

A thank you to Christina Farr:

We want to congratulate Christina Farr on her new role as a managing director at Manatt, where she will continue to advise companies on issues including investor relations, social media strategy, and other topics.

In light of this new role, we have decided that she will no longer work with us on agenda planning. We have great respect for Farr, who has contributed immensely to our planning process so far. We're grateful for her contributions and wish her the very best in her new role.

For event-related questions, email us at events@statsnews.com.